Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Levcromakalim in Post-Traumatic Headache
NCT05243953Completed
- Sponsor
- Dansk Hovedpinecenter
- Start
- Mar 2022
- Primary completion
- Jul 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial comparing Levcromakalim with Placebo (2 arms). Primary endpoint: Incidence of Migraine-Like Headache at 12 hours. Started Mar 2022; status: completed.
02
Drugs
levcromakalim
Beyond the preview
Go deeper on NCT05243953.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05243953.